Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 17.91
-0.05 (-0.28%)
Sep 10, 2026, 2:40 PM CST
SHE:300119 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 8,155 | 8,523 | 8,470 | 7,574 | 8,633 | 11,197 | |
Market Cap Growth | -19.79% | 0.62% | 11.83% | -12.26% | -22.90% | 48.13% |
Enterprise Value | 8,636 | 8,643 | 8,463 | 7,031 | 8,050 | 11,620 |
Last Close Price | 17.96 | 18.35 | 17.76 | 15.47 | 17.27 | 21.91 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 23.43 | 21.28 | 28.17 | 16.70 | 24.90 | 27.13 |
Forward PE | 17.88 | 16.59 | 16.49 | 14.66 | 17.95 | 19.57 |
PS Ratio | 2.39 | 2.51 | 2.76 | 2.80 | 4.14 | 5.58 |
PB Ratio | 1.59 | 1.64 | 1.69 | 1.52 | 1.92 | 2.59 |
P/TBV Ratio | 2.15 | 2.26 | 2.40 | 1.85 | 2.22 | 3.01 |
P/FCF Ratio | 47.49 | 70.19 | 15.40 | 47.80 | 506.25 | 145.88 |
P/OCF Ratio | 22.92 | 28.65 | 11.52 | 18.47 | 22.17 | 29.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.53 | 2.54 | 2.76 | 2.60 | 3.86 | 5.79 |
EV/EBITDA Ratio | 14.14 | 14.58 | 14.87 | 13.59 | 17.58 | 26.46 |
EV/EBIT Ratio | 22.08 | 22.61 | 22.57 | 18.57 | 22.97 | 32.72 |
EV/FCF Ratio | 50.29 | 71.18 | 15.38 | 44.37 | 472.04 | 151.39 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.32 | 0.28 | 0.28 | 0.18 | 0.20 | 0.17 |
Debt / EBITDA Ratio | 2.65 | 2.42 | 2.38 | 1.71 | 1.88 | 1.65 |
Debt / FCF Ratio | 9.41 | 12.03 | 2.51 | 5.66 | 51.47 | 9.63 |
Net Debt / Equity Ratio | 0.01 | -0.04 | -0.11 | -0.18 | -0.23 | -0.29 |
Net Debt / EBITDA Ratio | 0.11 | -0.39 | -0.98 | -1.79 | -2.23 | -2.89 |
Net Debt / FCF Ratio | 0.37 | -1.92 | -1.01 | -5.83 | -60.03 | -16.55 |
Asset Turnover | 0.43 | 0.44 | 0.41 | 0.41 | 0.35 | 0.42 |
Inventory Turnover | 3.99 | 4.00 | 3.65 | 3.54 | 2.95 | 2.68 |
Quick Ratio | 1.33 | 1.47 | 1.37 | 1.85 | 2.06 | 2.37 |
Current Ratio | 1.62 | 1.79 | 1.62 | 2.22 | 2.36 | 2.72 |
Return on Equity (ROE) | 7.52% | 8.53% | 6.60% | 10.86% | 8.47% | 12.28% |
Return on Assets (ROA) | 3.10% | 3.06% | 3.13% | 3.61% | 3.71% | 4.63% |
Return on Invested Capital (ROIC) | 7.29% | 7.51% | 7.90% | 9.06% | 9.69% | 11.17% |
Return on Capital Employed (ROCE) | 6.90% | 6.60% | 6.60% | 7.00% | 7.30% | 7.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.27% | 4.70% | 3.55% | 5.99% | 4.02% | 3.69% |
FCF Yield | 2.11% | 1.43% | 6.50% | 2.09% | 0.20% | 0.69% |
Dividend Yield | 2.31% | 2.18% | 1.69% | 2.59% | 1.74% | 1.60% |
Payout Ratio | 52.18% | 41.82% | 71.75% | 36.00% | 54.92% | 43.99% |
Buyback Yield / Dilution | 0.73% | 1.29% | 0.69% | -0.11% | -15.06% | -1.61% |
Total Shareholder Return | 3.04% | 3.47% | 2.38% | 2.48% | -13.32% | -0.01% |